• Login
  • Register
  • CVRF's Meetings
    TCTAP AP VALVES COMPLEX PCI

SummitMD SummitMD

TCTAP 2021 Virtual
  • Home
  • News
  • Videos
    • TCTAP
    • AP VALVES
    • COMPLEX PCI
    • ACT PROGRAM
  • Topics
    • Coronary
    • Endovascular
    • Structural Heart Disease
    • Valve
    • Imaging & Physiology
    • Pharmacology
  • Book
  • Conferences
    • TCTAP
    • AP VALVES
    • COMPLEX PCI
  • About CVRF
    • Mission
    • Board Members
    • R&D Divisions
      • Clinical Research Coordinating Center
      • Translational Research Center
      • Research Activity
      • Paper Publication
    • Education Programs
      • ACT Program
      • Fellowship Training Program
    • Management Team
    • Policy

Pharmacology

  • Home
  • Topics

Slide

No Title Presenter Date
87 Antithrombotic Strategy in PCI and AF Patients: Updated Strategy Alan C. Yeung Nov. 27. 19
86 Antithrombotic Strategy in HBR Patients: Updated Strategy Joo-Yong Hahn Nov. 27. 19
85 Antithrombotic and Antiplatelet Choice in Complex PCI Duk-Woo Park Nov. 27. 19
84 [TCTAP A-093] Determinants of Self-Discontinuation of Secondary Prevention Medications by Coronary Heart Disease Outpatients: Focus on the Role of Erectile Dysfunction Muhamad Ali SK Abdul Kader Apr. 20. 15
83 [TCTAP A-001] Outcomes of 6 Months Versus 12 Months Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Biolimus or Durable Polymer Zotarolimus-Eluting Stents: OPTIMA-C Study and Optical Coherence Tomography Sub-Study Byoung Kwon Lee Apr. 20. 15
82 The Role of Triple Antiplatelet Therapy in Patients with High Risk Young-Hoon Jeong Jul. 22. 09
81 Tailoring Treatment to Risk in Antiplatelet Therapy Alexandra J. Lansky Jul. 22. 09
80 What Is the Optimal Duration of DAPT Following DES Treatment? David E. Kandzari Jul. 22. 09
79 Anti-Platelet Therapies in Cardiovascular Disease: From Stable CAD to ACS and Afib Roxana Mehran Jul. 22. 09
78 Strategic Approaches to Obtain Better and Earlier CV Outcome Weon Kim Jul. 22. 09
1 2 3 4 5 6 7 8 9

Case

No Title Operator Date
1 Sudden Cardiac Death After Drug-Eluting Stent Implantation and Interruption of Antiplatelet Therapy [7] Sang-Sig Cheong Jan. 13. 06
1
Pharmacology
  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others
Conference
  • TCTAP
  • AP VALVES
  • COMPLEX PCI

Upcoming Events

TCTAP 2021
COMPLEX PCI 2021
CardioVascular Research Foundation

2F Asan Institute for Education & Research, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
Business Registration Number: 215-82-06387

Privacy PolicyContact Us

The Latest News
  • NIRS-IVUS Imaging to identify Vulnerable Plaques, At-Risk Patients / ViV TAVR for patients with failing SBV20-11-13
  • Coronary CTA on Asymptomatic Patients20-10-23
  • POPular TAVI: Aspirin with or without clopidogrel after TAVI20-10-16
Sign up for CVRF e-newsletter
Porto Website Template

Copyright 2020. All Rights Reserved.